Sally A. Smith
Direttore/Membro del Consiglio presso The Murtis H. Taylor Multi-Services Center
Provenienza dei contatti di primo grado di Sally A. Smith
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
The Murtis H. Taylor Multi-Services Center
The Murtis H. Taylor Multi-Services Center Services to the Health IndustryHealth Services The Murtis H. Taylor Multi-Services Center provides healthcare and community services to individuals and families. Its services include adult and children outpatient therapy, psychiatric and nursing, case management community support, dual diagnosis specialized treatment, partial hospitalization treatment, socialization programs, prevention, community education, family support, residential and housing services. The company was founded by Murtis H. Taylor in 1948 and is headquartered in Cleveland, OH.
20
| Non-Profit Organization | Services to the Health Industry | 20 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Sally A. Smith tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
IMMUNOMEDICS, INC. | Biotechnology | Chief Executive Officer | |
IBC Pharmaceuticals, Inc.
IBC Pharmaceuticals, Inc. BiotechnologyHealth Technology Part of Gilead Sciences, Inc., IBC Pharmaceuticals, Inc. is a company that produces biological products. The company is based in Morris Plains, NJ. | Biotechnology | President | |
Fairleigh Dickinson University | College/University | Graduate Degree | |
Merrimack College | College/University | Undergraduate Degree | |
University of Technology Sydney | College/University | Graduate Degree | |
Victoria University of Wellington | College/University | Graduate Degree | |
HealthCare Institute of New Jersey | Director/Board Member | ||
Vaneltix Pharma, Inc.
Vaneltix Pharma, Inc. Pharmaceuticals: MajorHealth Technology Urigen Pharmaceuticals, Inc. is a specialty pharmaceutical company which focuses on the development and commercialization of innovative products for urology indications. It is specialized in the design and implementation of products for patients with urological ailments, including products for amelioration of bladder pain syndrome and interstitial cystitis. The company was founded in March 1999 and is headquartered in North Brunswick, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Novotech (Australia) Pty Ltd.
Novotech (Australia) Pty Ltd. BiotechnologyHealth Technology Novotech (Australia) Pty Ltd. operates as a contract research organization. It provides clinical development services across all clinical trial phases and therapeutic areas including: feasibility assessments; ethics committee and regulatory submissions, data management, statistical analysis, medical monitoring, safety services and central lab services. The firm offers patient recruitment and site selection, clinical operations and project management, medical and regulatory consulting, biometrics and data management solutions. The company was founded by Alek Safarian in 1996 and is headquartered in Sydney, Australia. | Biotechnology | Director/Board Member | |
Novartis Pharmaceuticals Australia Pty Ltd.
Novartis Pharmaceuticals Australia Pty Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis Pharmaceuticals Australia Pty Ltd. is a company based in Sydney, Australia. | Pharmaceuticals: Major | General Counsel | |
Novotech Health Holdings Ltd.
Novotech Health Holdings Ltd. BiotechnologyHealth Technology Novotech Health Holdings Ltd. operates as a biotech-focused full-service contract research organization. Its integrated CRO platform provides clinical trial services ranging from consulting services prior to the commencement of the clinical phase to late-phase clinical trials. The firm’s services include: clinical trial services which include clinical research, bioequivalence and pharmacodynamics research, and drug development consulting services; and its related clinical trial services which include laboratory, site management organization, flexible insourcing and Phase I clinical trial unit services. The company was founded on February 25, 2020 and is headquartered in Singapore. | Biotechnology | Compliance Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 8 |
Australia | 4 |
Nuova-Zelanda | 2 |
Hong Kong | 2 |
Settori
Health Technology | 7 |
Consumer Services | 5 |
Electronic Technology | 2 |
Posizioni
Director/Board Member | 22 |
President | 3 |
Graduate Degree | 3 |
General Counsel | 3 |
Chief Executive Officer | 2 |
Contatti più connessi
- Borsa valori
- Insiders
- Sally A. Smith
- Connessioni Società